Plasma levels of trefoil factors are increased in patients with advanced prostate cancer

E.M. Vestergaard, Michael Krabbe Borregaard, Steen Seier Poulsen, E. Nexo, N. Torring

59 Citations (Scopus)

Abstract

Through cDNA array analyses and immunohistochemistry on tissue microarrays, trefoil factor 3 (TFF3) was recently shown to be overexpressed in prostate cancer. The purpose of this study was to test the feasibility of using the levels of trefoil factors as a plasma marker for prostate cancer.
Original languageEnglish
JournalClinical Cancer Research
Volume12
Issue number3 Pt 1
Pages (from-to)807-812
Number of pages6
ISSN1078-0432
DOIs
Publication statusPublished - 2006

Keywords

  • Aged
  • Aged, 80 and over
  • Enzyme-Linked Immunosorbent Assay
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Peptides
  • Prospective Studies
  • Prostate-Specific Antigen
  • Prostatic Neoplasms
  • Sensitivity and Specificity
  • Tumor Suppressor Proteins

Fingerprint

Dive into the research topics of 'Plasma levels of trefoil factors are increased in patients with advanced prostate cancer'. Together they form a unique fingerprint.

Cite this